In primary monocytes from HD, the NLRP3 inflammasome-specific inhibitor MCC950 completely inhibited LPS/nigericin-induced IL-1β secretion and LDH release (Supplementary Fig. 2e). The gene discussed is NLRP3; the disease is Huntington disease.